CM
OLMA icon

Caption Management’s Olema Pharmaceuticals OLMA Stock Holding History

Caption Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Sell
30,000
-46,000
-61% -$616K ﹤0.01% 1380
2026
Q1 		$1.13M Buy
+76,000
New +$1.69M 0.01% 988

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Caption Management's OLMA Position: Q2 2026 in Review

Caption Management reduced its Olema Pharmaceuticals (OLMA) stake by 49% in Q2 2026, selling an estimated $228K and leaving 18,000 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Caption Management first reported a position in OLMA in Q4 2023 and has held it in 5 quarters since. The position peaked at $522K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Caption Management held 18,000 shares of Olema Pharmaceuticals worth $225K as of Q2 2026.
  • Caption Management sold 17,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $228K.
  • Olema Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1450 holding.
  • Caption Management first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Caption Management's Olema Pharmaceuticals position peaked at $522K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.